MeVis Medical Solutions AG (ETR:M3V)
Germany · Delayed Price · Currency is EUR 23.60
0.00 (0.00%)
Aug 5, 2026, 5:35 PM CET
ETR:M3V Income Statement
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 15.48 | 16.06 | 16.97 | 17.34 | 18.76 | 16.21 | |
Revenue Growth | -3.60% | -5.36% | -2.14% | -7.57% | 15.71% | -5.35% |
Cost of Revenue | 0.33 | 0.37 | 0.49 | 0.45 | 0.75 | 0.44 |
Gross Profit | 15.15 | 15.69 | 16.48 | 16.9 | 18.01 | 15.78 |
Selling, General & Admin | 12.02 | 10.81 | 10.05 | 9.89 | 9.42 | 8.85 |
Depreciation & Amortization Expenses | -0.15 | -0.15 | -0.13 | -0.1 | -0.09 | -0.13 |
Other Operating Expenses | -2.54 | -2.59 | -2.8 | -3.01 | -0.8 | -2.32 |
Total Operating Expenses | 9.32 | 8.07 | 7.12 | 6.79 | 8.53 | 6.41 |
Operating Income | 5.83 | 7.62 | 9.37 | 10.11 | 9.48 | 9.37 |
Interest Income | 1.04 | 1.14 | 1.21 | 1.18 | 0.18 | 0.16 |
Interest Expense | - | -0 | -0.02 | -0.04 | -0 | -0.01 |
Total Non-Operating Income (Expense) | 1.04 | 1.14 | 1.19 | 1.14 | 0.17 | 0.15 |
Pretax Income | 6.86 | 8.76 | 10.55 | 11.25 | 9.66 | 9.52 |
Provision for Income Taxes | 0.1 | 0.11 | 0.13 | 0.11 | 0.09 | 0.09 |
Minority Interest in Earnings | 1.38 | 3.17 | 4.56 | 4.92 | 7.79 | 4.55 |
Net Income to Common | -1.38 | -3.17 | -4.56 | -4.92 | -7.79 | -4.55 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 2 | 2 | 2 | 2 | 2 | 2 |
Shares Outstanding (Diluted) | 2 | 2 | 2 | 2 | 2 | 2 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | -0.76 | -1.74 | -2.51 | -2.70 | -4.28 | -2.50 |
EPS (Diluted) | -0.76 | -1.74 | -2.51 | -2.70 | -4.28 | -2.50 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | - | 3.74 | 2.84 | 5.77 | 4.72 | 9.08 |
Free Cash Flow Growth | - | 31.44% | -50.74% | 22.23% | -47.97% | 225.78% |
Free Cash Flow Per Share | - | 2.05 | 1.56 | 3.17 | 2.60 | 4.99 |
Dividends Per Share | 1.130 | 1.130 | 1.130 | 0.950 | - | - |
Dividend Growth | 0% | 0% | 18.95% | - | - | - |
Gross Margin | 97.84% | 97.70% | 97.11% | 97.43% | 96.02% | 97.31% |
Operating Margin | 37.62% | 47.44% | 55.19% | 58.30% | 50.55% | 57.77% |
FCF Margin | - | 23.28% | 16.76% | 33.30% | 25.18% | 56.00% |
EBITDA | 5.83 | 7.77 | 9.5 | 10.21 | 9.58 | 9.49 |
EBITDA Margin | 37.62% | 48.36% | 55.97% | 58.85% | 51.05% | 58.54% |
EBIT | 5.83 | 7.62 | 9.37 | 10.11 | 9.48 | 9.37 |
EBIT Margin | 37.62% | 47.44% | 55.19% | 58.30% | 50.55% | 57.77% |
Effective Tax Rate | 1.39% | 1.29% | 1.20% | 1.01% | 0.90% | 0.89% |